Platelets drive fibronectin fibrillogenesis using integrin αIIbβ3.pdf (2.21 MB)
Platelets drive fibronectin fibrillogenesis using integrin αIIbβ3
journal contribution
posted on 2022-06-08, 15:52 authored by Sebastian Lickert, Martin Kenny, Kateryna Selcuk, Johanna L Mehl, Markus Bender, Susanna M Früh, Melanie A Burkhardt, Jan-Dirk Studt, Bernhard Nieswandt, Ingmar SchoenIngmar Schoen, Viola VogelPlatelets interact with multiple adhesion proteins during thrombogenesis, yet little is known about their ability to assemble fibronectin matrix. In vitro three-dimensional superresolution microscopy complemented by biophysical and biochemical methods revealed fundamental insights into how platelet contractility drives fibronectin fibrillogenesis. Platelets adhering to thrombus proteins (fibronectin and fibrin) versus basement membrane components (laminin and collagen IV) pull fibronectin fibrils along their apical membrane versus underneath their basal membrane, respectively. In contrast to other cell types, platelets assemble fibronectin nanofibrils using αIIbβ3 rather than α5β1 integrins. Apical fibrillogenesis correlated with a stronger activation of integrin-linked kinase, higher platelet traction forces, and a larger tension in fibrillar-like adhesions compared to basal fibrillogenesis. Our findings have potential implications for how mechanical thrombus integrity might be maintained during remodeling and vascular repair.
Funding
ETH Zurich, Swiss TransMed “Life Matrix” 33/2013
Wyss Zurich
Velux Stiftung
TR240 grant with project number 374031971 of the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)
Science Foundation Ireland under grant number 19/FFP/6708
Royal College of Surgeons in Ireland
European Union’s Horizon 2020 research and innovation programme under grant agreement no. 747586
History
Comments
The original article is available at https://www.science.org/Published Citation
Lickert S. et al. Platelets drive fibronectin fibrillogenesis using integrin αIIbβ3. Sci Adv. 2022;8(10):eabj8331Publication Date
11 Mar 2022External DOI
PubMed ID
35275711Department/Unit
- Irish Centre for Vascular Biology
- School of Pharmacy and Biomolecular Sciences
Research Area
- Vascular Biology
- Biomaterials and Regenerative Medicine
Publisher
American Association for the Advancement of Science (AAAS)Version
- Published Version (Version of Record)